SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-061294
Filing Date
2023-07-31
Accepted
2023-07-31 16:15:38
Documents
109
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2023_chinasxtphar.htm   iXBRL 20-F 2209916
2 DESCRIPTION OF REGISTERED SECURITIES f20f2023ex2-2_chinasxt.htm EX-2.2 112337
3 CERTIFICATION f20f2023ex12-1_chinasxt.htm EX-12.1 11893
4 CERTIFICATION f20f2023ex12-2_chinasxt.htm EX-12.2 12162
5 CERTIFICATION f20f2023ex13-1_chinasxt.htm EX-13.1 4007
6 CONSENT OF INDEPENDENT AUDITORS f20f2023ex23-1_chinasxt.htm EX-23.1 4833
7 GRAPHIC image_001.jpg GRAPHIC 27199
8 GRAPHIC image_002.jpg GRAPHIC 4745
9 GRAPHIC image_003.jpg GRAPHIC 2880
10 GRAPHIC ex23-1_001.jpg GRAPHIC 4745
11 GRAPHIC ex23-1_002.jpg GRAPHIC 2880
  Complete submission text file 0001213900-23-061294.txt   9480205

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE sxtc-20230331.xsd EX-101.SCH 110079
13 XBRL CALCULATION FILE sxtc-20230331_cal.xml EX-101.CAL 44636
14 XBRL DEFINITION FILE sxtc-20230331_def.xml EX-101.DEF 395375
15 XBRL LABEL FILE sxtc-20230331_lab.xml EX-101.LAB 733681
16 XBRL PRESENTATION FILE sxtc-20230331_pre.xml EX-101.PRE 413547
103 EXTRACTED XBRL INSTANCE DOCUMENT f20f2023_chinasxtphar_htm.xml XML 1166161
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-38773 | Film No.: 231127589
SIC: 2834 Pharmaceutical Preparations